Resultados da busca por Autor

1

Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanc...

por Salata, Robert A.

Publicado em 2023

Outros Autores: “...Kanyama, Cecilia...”
Acessar documento

Artigo

2

Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease

por Périssé, André R. S.

Publicado em 2013

Outros Autores: “...Kanyama, Cecilia...”
Acessar documento

Artigo

3

Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy

por Shivakoti, Rupak

Publicado em 2014

Outros Autores: “...Kanyama, Cecilia...”
Acessar documento

Artigo

4

C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral th...

por Tenforde, Mark W.

Publicado em 2015

Outros Autores: “...Kanyama, Cecilia...”
Acessar documento

Artigo

5

Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study

por Shivakoti, Rupak

Publicado em 2018

Outros Autores: “...Kanyama, Cecilia...”
Acessar documento

Artigo

6

Pre-cART elevation of CRP and CD4+ T-Cell immune activation associated with HIV clinical progression in a multinational case-cohort study

por Balagopal, Ashwin

Publicado em 2015

Outros Autores: “...Kanyama, Cecilia...”
Acessar documento

Artigo

7

Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 wee...

por Avihingsanon, Anchalee

Publicado em 2022

Outros Autores: “...Kanyama, Cecilia...”
Acessar documento

Artigo

Exportar CSV Exportar RIS